Clopidogrel reduced a composite of death from any cause, myocardial infarction (MI), or stroke events by an absolute 2.2 ...

CDSCO asks States and UTs to act upon list of 35 FDCs declared as new drugs: Gireesh Babu, New Delhi Wednesday, April 16, 2025, 08:00 Hrs [IST] The Drugs Controller General of Ind ...

Between August 2020 and July 2023, in an open-label trial, 5,506 patients at 26 sites across South Korea (median age 65.0 years, 18.2% women) who underwent PCI were randomized 1:1 to either ...

Patients with a PRU value outside this range were excluded. Patients were placed on aspirin (minimum 81 mg/day for 7 days) and clopidogrel (minimum 75 mg/day for 7 days) prior to PED placement.

According to the results of randomisation, patients in the DAPT group will be given aspirin 100 mg+clopidogrel 75 mg/day for 12 weeks, and patients in the DOAC group will be given rivaroxaban (15 ...

The patients received two dual antiplatelet therapy regimens: 100 mg/d aspirin and 75 mg/d clopidogrel (from March 2019 to February 2021), and 100 mg/d aspirin and 90 mg 90 mg/bid ticagrelor (from ...

The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug ...

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed retail prices of 80 formulations under ...

People at risk of a cardiac event after a percutaneous coronary intervention (PCI) stent procedure who received long-term antiplatelet therapy with clopidogrel were 29% less likely to die than ...